Source news

dow-jones News

20 stories
dow-jones

Cadrenal Therapeutics Names Sharp Interim CFO

By Elias SchisgallCadrenal Therapeutics named John Sharp as its interim chief financial officer.Sharp will succeed Quang Pham, who had been serving as interim CFO. The company said it is conducting a search for a permanent finance chief.Sharp is currently a senior director at Lohman & Associates, a…

Dow Jones Newswires en
StocksUS
dow-jones

Mama's Creations Shares Slide Ahead of Share Sale

By Doc LouallenMama's Creations shares declined after the company launched an underwritten public offering of its common stock.Shares slid 13% to $17.91 in after-hours trading on Monday. The stock touched a 52-week high of $21.00 in the market session, and is up 53% this year.The company said all s…

Dow Jones Newswires en
StocksUS
dow-jones

Nuvectis Pharma Stock Falls on Public Stock Offering Plans

By Elias SchisgallShares of Nuvectis Pharma fell after the company said it plans to launch an underwritten public stock offering.Shares fell 18% to $23.26 in after-hours trading on Monday. The stock closed up 4.9% at $28.53, up nearly fourfold since the start of the year.The company did not say how…

Dow Jones Newswires en
StocksUS
dow-jones

Vishay Intertechnology Shares Fall on Planned $750M Stock Offering

By Elias SchisgallShares of Vishay Intertechnology slid after the company said it plans to launch an underwritten public offering for $750 million of stock.The stock slipped 11%, to $50.25, after the bell on Monday. Shares closed roughly flat, at $56.28, and are up nearly fourfold this year.The com…

Dow Jones Newswires en
StocksUS
dow-jones

Concentrix Shares Slide on Lowered FY Outlook, Tepid 3Q Guidance

By Elias SchisgallShares of Concentrix slid after the company cut its full-year outlook and projected third-quarter results behind Wall Street's expectations.Shares were down 23% to $19.47 in after-hours trading on Monday. The stock closed up 0.9% at $25.23, down 39% this year.The customer-experien…

Dow Jones Newswires en
StocksUS

Canada Approves Apotex's Bid to Sell Generic Version of Wegovy

By Paul VieiraOTTAWA--Canadian regulators approved Apotex's bid to manufacture a generic version of the weight-loss drug Wegovy.Canada's health department, which is in charge of drug approvals, said Monday it authorized Apotex's bid following a review of evidence from the company that meets the reg…

Dow Jones Newswires en
StocksCADK
NEWS dow-jones

Exchange Traded Funds Top 10 Volume Leaders

NET % VOL STOCK (Symbol) LAST CHG CHG 100s Direxion Semicon Br 3x SOXS 3.72 -0.52 -12.26 769,737,829 Direxion SC Bear 3x TZA 3.85 -0.04 -1.03 335,086,476 ProShares Bitcoin ETF BITO 8…

Dow Jones Newswires en
ETFs
NEWS dow-jones

Exchange Traded Funds Top 10 Percentage Losers

NET % STOCK (Symbol) LAST CHG CHG Defiance Tgt 2x Shrt RKLB RKLZ 2.72 -1.29 -32.17 Defiance Dly Tgt 2x Sh SMST 70.07 -24.81 -26.15 Defiance Tgt 2x Shrt IONQ IONZ 2.54 -0.58 -18.59 GrShr 2x Sh TSLA Daily TSDD 7…

Dow Jones Newswires en
NEWS dow-jones

Exchange Traded Funds Top 10 Percentage Gainers

NET % STOCK (Symbol) LAST CHG CHG Defiance Tgt 2X Lg RKLB RKLX 41.41 9.94 31.59 Defiance Dly Tgt 2x Lg MSTX 8.48 1.72 25.44 Leverage 2x Lg KLAC Dly KLAG 64.50 12.93 25.07 GrShr 2x Long MSTR Daily MSTP 12…

Dow Jones Newswires en
dow-jones

Tilray Brands Acquires HelloMD to Expand Medical Cannabis Platform

By Anvee BhutaniTilray Brands said Monday it acquired HelloMD, a digital healthcare and patient engagement platform, expanding its direct-to-patient medical cannabis business in Canada and supporting its global growth strategy.Financial terms of the deal weren't disclosed. Tilray said it was the su…

Dow Jones Newswires en
StocksCA
NEWS dow-jones

Nymex Natural Gas Delivery Intentions Breakdown - Jun 29

Source: CME Group JULY 2026 NATURAL GAS HENRY HUB FUTURE INTENT DATE: 06/29/2026 FIRM NBR ORIG FIRM NAME ISSUED STOPPED 072 CUST GOLDMAN 688 155 072 HOUS GOLDMAN 403 077 HOUS BP ENERGY COMPANY…

Dow Jones Newswires en
Futures
dow-jones

Canada Approves Apotex's Bid to Sell Generic Version of Wegovy

By Paul VieiraOTTAWA--Canadian regulators approved Apotex's bid to manufacture a generic version of the weight-loss drug Wegovy.Canada's health department, which is in charge of drug approvals, said Monday it authorized Apotex's bid following a review of evidence from the company that meets the reg…

Dow Jones Newswires en
StocksCA